跳至主要内容
临床试验/CTRI/2025/02/080934
CTRI/2025/02/080934尚未招募3 期

A Comparative Clinical Study to evaluate the effect of Varunadi Taila and Kulattadhya Ghrita Matrabasthi followed by Swadamshtradi Kwatha in Mootrashmari Vis-a-Vis Urolithiasis

DR POOJA BG1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2025年2月19日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
40
试验地点
1
主要终点
Evaluating the efficacy of varunadi taila and kulattadhya ghrita Matrabasthi with Swadamshtradi Kashaya in relieving the symptoms of Mootrashmari like Hematuria ,pain abdomen, Burning micturition and difficulty in passing urine with size and number of the stone through pre and post test USG Abdomen and Pelvis

研究概览

简要总结

Mootrashmari is defined as formation of a stone like substance in Mootravaha srotas with symptoms like Mahati vedana Sarudhira mootrata Vedana in Nabhi and Basthi pradesha and  Mootradhara sanga In Sushruta samhitha  Mootrashmari is considered as one among the Ashta Mahagada

Majority of signs and symptoms of the disease Mootrashmari resembles that of Urolithiasis Urolithiasis is a condition where hard masses or calculi is formed and get collected in the urinary tract characterized by dull aching pain in both loins hematuria frequent micturition and difficulty in passing urine It is the third most common affliction of the urinary tract with a prevalence of about 12% worldwide Their prevalence in India also reflects worldwide prevalence and stands at approximately 12% Men are more commonly affected than female with a male to female ratio of 3:1 The peak age for developing calculi is between 30-50yrs. 7 Recurrence is common with 10% risk at lyear, 35% at 5year and nearly 50% at 10years

Untreated Urolithiasis can encompass complications like Acute renal failure resulting from obstruction  Anuria Urinary tract infection Sepsis and elevate the risk for Chronic kidney disease The treatment principle of Urolithiasis in contemporary science is flush therapy in case of stones up to 5mm in larger stones the advanced procedures like ESWL(Extracorporeal shock wave lithotripsy) and operative procedures like Percutaneous nephrolithotomy Pyelolithotomy Nephrolithotomy Nephrectomy are done But these procedures have limitations in various aspects like they are expensive invasive and many a times leads to complications such 16 as injury to colon injury to blood vessels and sepsis In Sushruta Samhita conservative management is emphasized in the initial stages of Ashmari and surgery in the longstanding complicated conditions In Ayurveda Basthikarma is considered as the prime modality and said to be Ardachikitsa 13 indicated in all Ekadoshaja Samsargaja Sannipataja disorders

Much importance is given to Trivida Bastikarma Niruha Anuvasana Uttara in the 14 management of Mootravahasrotovikara Ashtanga Sangraha explains the repeated 15 administration of Basti in the management of Mootrashmari Matra basti is one of the  subclasses of Basti Karma which is easy to administer without much limitations or 17 complications Though numerous studies have been conducted on the management of Mootrashmari, yet studies focused on Matrabasti are very less.

In Chakradatta, while discussing various formulations for Ashmari it is mentioned that Kulattadhya Ghrita and Varunadi Taila have properties like Sarva Prakara Ashmarihara and Ashmari Bhedana respectively. In Bhavaprakasha Swadamshtradi kwatha is said to have Ashmari shulaghna effects

The herbs mentioned in above said formulations are cost effective and widely accessible  Considering all the above factors the study to evaluate the efficacy of Varunadi taila and Kulattadhya ghrita Matrabasti followed by Swadamshtradi kwatha in Mootrashmari vis a vis Urolithiasis will be undertaken

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Subjects diagnosed to have urinary calculi (solitary or multiple) by USG Abdomen and pelvis will be included in the study Stones measuring less than 8mm by USG Abdomen and pelvis will be included Fresh and treated cases of Mootrashmari vis a vis Urolithiasis will be taken for the study Fresh cases including freshly detected and untreated cases of Mootrashmari vis a vis Urolithiasis Treated cases including individuals those who are under any treatment of Mootrashmari vis a vis Urolithiasis and are willing to voluntarily discontinued the ongoing treatment will be considered in those cases flush out period of 1 week will be advised with repeat USG abdomen and pelvis.

排除标准

  • Subjects with acute urinary colic which requires emergency management will be exchuded Subjects with impaired renal function test, Severe hydronephrosis, Oliguria/Anuria and complications requiring surgical management will be excluded Subjects with uncontrolled systemic disorders that might interfere with present intervention will be excluded.
  • Pregnant and Lactating mothers will be excluded from the study.
  • Subjects who are unfit for Basthikarma will be excluded.

结局指标

主要结局

Evaluating the efficacy of varunadi taila and kulattadhya ghrita Matrabasthi with Swadamshtradi Kashaya in relieving the symptoms of Mootrashmari like Hematuria ,pain abdomen, Burning micturition and difficulty in passing urine with size and number of the stone through pre and post test USG Abdomen and Pelvis

时间窗: Evaluating the efficacy of varunadi taila and kulattadhya ghrita Matrabasthi with Swadamshtradi Kashaya in relieving the symptoms of Mootrashmari like Hematuria ,pain abdomen, Burning micturition and difficulty in passing urine with size and number of the stone through pre and post test USG Abdomen and Pelvis | 0th day and 38th day

次要结局

  • Comparing the efficacy of varunadi taila and kulattadhya ghrita Matrabasthi with Swadamshtradi Kashaya in relieving the symptoms of Mootrashmari like Hematuria ,pain abdomen, Burning micturition and difficulty in passing urine with size and number of the stone through pre and post test USG Abdomen and Pelvis(0th day before the intervention USG Abdomen and Pelvis and on 39th day repeating USG Abdomen and pelvis after completion of intervention)

研究者

发起方
DR POOJA BG
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

DR POOJA BG

Government Ayurveda Medical College and Hospital Mysore

研究点 (1)

Loading locations...

相似试验

Ayurvedic Intervention in the Management of Kidney... | 临床试验